HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Youmin Pu Selected Research

monodansylcadaverine

3/2022TRPC6 ameliorates renal ischemic reperfusion injury by inducing Zn2+ influx and activating autophagy to resist necrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Youmin Pu Research Topics

Disease

2Ischemia
03/2022 - 09/2019
2Reperfusion Injury
03/2022 - 09/2019
1Necrosis
03/2022
1Chronic Kidney Failure (Chronic Renal Failure)
05/2021
1Nephritis
01/2020
1Chronic Renal Insufficiency
01/2020
1Inflammation (Inflammations)
09/2019
1Hypoxia (Hypoxemia)
09/2019

Drug/Important Bio-Agent (IBA)

2TRPC6 Cation ChannelIBA
03/2022 - 09/2019
1Transient Receptor Potential ChannelsIBA
03/2022
1Fluorescent Dyes (Fluorescent Probes)IBA
03/2022
1monodansylcadaverineIBA
03/2022
1Autophagy-Related ProteinsIBA
03/2022
1Long Noncoding RNAIBA
01/2020
1MicroRNAs (MicroRNA)IBA
01/2020
1Proteins (Proteins, Gene)FDA Link
09/2019
1Malondialdehyde (Propanedial)IBA
09/2019
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2019
1InterleukinsIBA
09/2019
1Sirtuin 2IBA
09/2019
1NADP (NADPH)IBA
09/2019
1necrostatin-1IBA
09/2019
1Phosphotransferases (Kinase)IBA
09/2019

Therapy/Procedure

1Kidney Transplantation
05/2021
1Operative Surgical Procedures
05/2021
1Meditation
09/2019